1. Home
  2. NNNN vs SDGR Comparison

NNNN vs SDGR Comparison

Compare NNNN & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$34.00

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$18.39

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
SDGR
Founded
2021
1990
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
NNNN
SDGR
Price
$34.00
$18.39
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$26.25
AVG Volume (30 Days)
34.4K
819.3K
Earning Date
04-28-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$8,185,146.00
$256,951,000.00
Revenue This Year
N/A
$23.69
Revenue Next Year
N/A
$20.46
P/E Ratio
$662.94
N/A
Revenue Growth
21.95
32.90
52 Week Low
$5.18
$15.99
52 Week High
$55.65
$28.47

Technical Indicators

Market Signals
Indicator
NNNN
SDGR
Relative Strength Index (RSI) 54.45 51.45
Support Level $31.18 $17.02
Resistance Level $35.55 $19.44
Average True Range (ATR) 5.14 0.79
MACD 0.14 0.15
Stochastic Oscillator 37.79 52.48

Price Performance

Historical Comparison
NNNN
SDGR

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Share on Social Networks: